0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1010B |
Carbon Tetrachloride, Blood |
1030B |
Carisoprodol and Metabolite, Blood |
1030FL |
Carisoprodol and Metabolite, Fluid |
1030SP |
Carisoprodol and Metabolite, Serum/Plasma |
1030U |
Carisoprodol and Metabolite, Urine |
1055B |
Celecoxib, Blood |
1055SP |
Celecoxib, Serum/Plasma |
1110B |
Chlorobenzene, Blood |
1110SP |
Chlorobenzene, Serum/Plasma |
1111U |
Chlorobenzene Exposure (p-Chlorophenol), Urine |
1130B |
Chloroform, Blood |
1255B |
Chlorzoxazone, Blood |
1255SP |
Chlorzoxazone, Serum/Plasma |
1306U |
Codeine - Total (Conjugated/Unconjugated) Screen, Urine |
1405B |
Cyclobenzaprine, Blood |
1405FL |
Cyclobenzaprine, Fluid |
1405SP |
Cyclobenzaprine, Serum/Plasma |
1405TI |
Cyclobenzaprine, Tissue |
1405U |
Cyclobenzaprine, Urine |
2423B |
Comprehensive Volatiles Panel, Blood |
8661B |
Codeine and Metabolite - Free (Unconjugated), Blood |
8661SP |
Codeine and Metabolite - Free (Unconjugated), Serum/Plasma |
8661U |
Codeine and Metabolite - Total (Conjugated/Unconjugated), Urine |
9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |